C WorldWide Group’s Heron Therapeutics HRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-1,202,069
| Closed | -$3.35M | – | 88 |
|
|
2022
Q2 | $3.35M | Hold |
1,202,069
| – | – | 0.04% | 68 |
|
|
2022
Q1 | $6.88M | Hold |
1,202,069
| – | – | 0.07% | 54 |
|
|
2021
Q4 | $11M | Hold |
1,202,069
| – | – | 0.1% | 46 |
|
|
2021
Q3 | $12.9M | Hold |
1,202,069
| – | – | 0.13% | 42 |
|
|
2021
Q2 | $18.7M | Hold |
1,202,069
| – | – | 0.19% | 38 |
|
|
2021
Q1 | $19.5M | Hold |
1,202,069
| – | – | 0.19% | 41 |
|
|
2020
Q4 | $25.4M | Buy |
1,202,069
+300,000
| +33% | +$6.35M | 0.25% | 33 |
|
|
2020
Q3 | $13.4M | Buy |
902,069
+200,000
| +28% | +$2.96M | 0.15% | 47 |
|
|
2020
Q2 | $10.3M | Hold |
702,069
| – | – | 0.12% | 51 |
|
|
2020
Q1 | $8.24M | Hold |
702,069
| – | – | 0.12% | 46 |
|
|
2019
Q4 | $16.5M | Hold |
702,069
| – | – | 0.2% | 37 |
|
|
2019
Q3 | $13M | Hold |
702,069
| – | – | 0.16% | 37 |
|
|
2019
Q2 | $13.1M | Buy |
702,069
+450,000
| +179% | +$8.37M | 0.16% | 47 |
|
|
2019
Q1 | $6.16M | Buy |
252,069
+120,471
| +92% | +$2.94M | 0.08% | 49 |
|
|
2018
Q4 | $3.41M | Sell |
131,598
-46,685
| -26% | -$1.21M | 0.05% | 59 |
|
|
2018
Q3 | $5.64M | Sell |
178,283
-32,729
| -16% | -$1.04M | 0.07% | 61 |
|
|
2018
Q2 | $8.2M | Buy |
211,012
+97,002
| +85% | +$3.77M | 0.11% | 46 |
|
|
2018
Q1 | $3.15M | Sell |
114,010
-17,590
| -13% | -$486K | 0.05% | 67 |
|
|
2017
Q4 | $2.38M | Buy |
131,600
+31,600
| +32% | +$572K | 0.03% | 79 |
|
|
2017
Q3 | $1.62M | Buy |
+100,000
| New | +$1.62M | 0.02% | 99 |
|